Transgender performers walk backstage during an event to mark World AIDS Day in 2013. A new WHO report demonstrates extremely rates of HIV infection among transgender women in 15 countries.
Prakash Mathema/AFP/Getty Images
سیستم بهداشت و مراقبت های درمانی در زن فراجنسییتی صورت درست و کاملی ندارد. همچنین نرخ اچ آی وی در این گروه از انسانها در وضعیت تکان دهنده ای قرار دارد.
Transgender people are not getting adequate health care, and widespreaddiscrimination is largely to blame, according to a recent World Health Organization report. And the story is told most starkly in the high rates of HIV among transgender women worldwide.
JoAnne Keatley, one of the authors of that study, puts it plainly.
“Just shocking rates,” she tells NPR’s Arun Rath. “There was a recent meta-analysis demonstrating that a transgender woman was 49 times as likely to be living with HIV [than the general population] in 15 countries in which data was looked at and analyzed.”
continue reading / weiterlesen / ادامه مطلب
1 December 2014
On World AIDS Day 2014, the World Health Organization will issue new recommendations to help countries close important gaps in HIV prevention and treatment services.
The guidelines will include advice on providing antiretroviral drugs for people who have been exposed to HIV – such as health workers, sex-workers, survivors of rape. They also include recommendations on preventing and managing common opportunistic infections and diseases such as severe bacterial and malaria infections, cryptococcal meningitis and the many oral and skin infections that can affect people living with HIV.
In 2013, WHO published consolidated guidelines on the use of antiretrovirals that promote earlier, simpler and less toxic interventions to keep people healthier for longer, and to help prevent HIV transmission. A growing number of countries with a high burden of HIV have adopted these guidelines. In 2013, a record 13 million people were able to access life-saving ARVs.
But too many people still lack access to comprehensive HIV treatment and prevention services. The 1 December supplement to the WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, released in June 2013, aims to help bridge that gap.